CN219307603U

CN219307603U - Electronic pulse medicine feeder

Info

Publication number: CN219307603U
Application number: CN202320077946.2U
Authority: CN
Inventors: 刘思维; 刘俐; 马奕阳
Original assignee: Individual
Current assignee: Individual
Priority date: 2023-01-10
Filing date: 2023-01-10
Publication date: 2023-07-07
Anticipated expiration: 2033-01-10

Abstract

The utility model discloses an electronic pulse medicine feeder which comprises a medicine feeding body, a suction nozzle, an atomization component and a temperature control component. The drug delivery body is provided with a drug carrying bin and an atomization cavity, and the drug carrying bin is suitable for carrying a drug liquid bottle. The suction nozzle is arranged on the drug administration body and communicated with the mist outlet end of the atomization cavity. The atomizing assembly is fixed in the atomizing cavity for atomizing the liquid medicine. The temperature control assembly comprises a controller and a medicine identifier electrically connected with the controller, the controller is arranged in the medicine feeding body and electrically connected with the atomizing assembly, and the medicine identifier is arranged in the medicine carrying bin and is used for reading medicine label signals of a medicine liquid bottle in the medicine carrying bin; the controller is used for controlling the atomizing temperature of the atomizing assembly according to the medicine label signal. The utility model improves the use efficiency of the drug feeder, can heat different drugs to the corresponding proper temperature, and realizes one-device multi-purpose. In addition, the problem that the medicine effect is lost or changed due to the fact that the molecular structure of the medicine is damaged is avoided, and the medicine effect of the medicine is guaranteed.

Description

Electronic pulse medicine feeder

Technical Field

The utility model relates to the technical field of ultrasonic atomizers, in particular to an electronic pulse drug feeder.

Background

In the medical field, electronic pulse applicators may be used for aerosol inhalation therapy, also known as ultrasonic nebulizers. The medical ultrasonic atomizer is mainly used for treating various upper and lower respiratory diseases, such as common cold, fever, cough, asthma, sore throat, pharyngitis, rhinitis, bronchitis, pneumoconiosis and other diseases in the trachea, bronchus, alveolus and chest. The aerosol inhalation treatment is an important and effective treatment method in respiratory system diseases, and adopts a drug feeder to atomize the liquid medicine into tiny particles, and the drug enters the respiratory tract and lung to deposit in a respiratory inhalation mode, so that the purpose of painless, rapid and effective treatment is achieved.

The medicine carrying bin of the existing electronic pulse medicine feeder is provided with a heating device, but the heating device does not have a temperature control and regulation function, so that the medicine carrying bin can not be heated according to different medicines in a targeted manner, only a single medicine can be heated and atomized, and if a user wants to match different medicines, the whole instrument needs to be purchased again. The service efficiency is greatly reduced, and the multifunctional device cannot be used. And after the medicine is heated to an excessive temperature, the molecular structure is completely destroyed, and the medicine effect is lost. Even change the drug effect, and cause the drug to generate toxicity.

Disclosure of Invention

The utility model mainly aims to provide an electronic pulse drug feeder, which aims to heat different drugs to the corresponding proper temperature so as to improve the service efficiency of the drug feeder and realize multiple purposes of one device; and avoid the problem of drug effect loss or drug effect change caused by the damage of the molecular structure of the drug, so as to ensure the drug effect of the drug.

To achieve the above object, the present utility model provides an electronic pulse applicator comprising:

the medicine delivery body is provided with a medicine carrying bin and an atomization cavity communicated with the medicine carrying bin, and the medicine carrying bin is suitable for loading a medicine liquid bottle;

the suction nozzle is arranged on the medicine feeding body and is communicated with the mist outlet end of the atomizing cavity;

the atomizing assembly is fixed in the atomizing cavity and is used for atomizing the liquid medicine; and

the temperature control assembly comprises a controller and a medicine identifier electrically connected with the controller, the controller is arranged in the medicine feeding body and electrically connected with the atomizing assembly, and the medicine identifier is arranged in the medicine carrying bin and is used for reading medicine label signals of a medicine liquid bottle in the medicine carrying bin; and the controller is used for controlling the atomizing temperature of the atomizing assembly according to the medicine label signal.

Optionally, the atomization assembly comprises an atomization sheet and a sterile cotton stick, wherein the atomization sheet is connected with the sterile cotton stick, and the sterile cotton stick is suitable for being inserted into a liquid medicine bottle; the atomization sheet is used for atomizing atomization liquid contained in the sterile cotton stick through variable frequency vibration.

Optionally, a heating cavity is arranged in the suction nozzle or the administration body, and the heating cavity is communicated with the atomizing cavity; the atomizing assembly further comprises a heating element which is arranged in the heating cavity and is electrically connected with the controller; the controller is also used for controlling the heating element to heat the liquid medicine water drops and the atomized gas in the heating cavity.

Optionally, the temperature control assembly further comprises a temperature sensor, and the temperature sensor is arranged at the mist outlet end of the heating cavity and is electrically connected with the controller; the temperature sensor is used for detecting a mist outlet temperature signal of the atomizing gas in the heating cavity, and the controller is also used for controlling the atomizing sheet and/or the heating element to work according to the mist outlet temperature signal.

Optionally, the heating element is a heating wire metal tube, one end of the heating wire metal tube is communicated with the atomizing cavity, the other end of the heating wire metal tube is communicated with the suction nozzle, and a communication hole communicated with the heating cavity is formed in the heating wire metal tube.

Optionally, the drug identifier is an RFID radio frequency identifier or a camera.

Optionally, the electronic pulse applicator further comprises an air switch mounted in the applicator body and electrically connected to the controller.

Optionally, the medicine delivery body includes a medicine carrying tube and an atomization tube, the medicine carrying tube forms the medicine carrying bin, the atomization tube forms the atomization cavity, the medicine carrying tube and the atomization tube are connected through magnetic attraction and are fixed through a locking structure.

Optionally, be equipped with the atomizing passageway in the atomizing section of thick bamboo, the one end of atomizing passageway is located atomizing subassembly's play fog end, the other end of atomizing passageway with the fog end intercommunication of intaking of suction nozzle is used for guiding fog to in the suction nozzle.

Optionally, the medicine carrying cartridge is further formed with a battery compartment which is arranged at a distance from the medicine carrying compartment, a rechargeable battery is arranged in the battery compartment, and the rechargeable battery is electrically connected with the controller.

In the technical scheme of the utility model, the electronic pulse medicine feeder comprises a medicine feeding body, a suction nozzle, an atomization component and a temperature control component; the drug delivery body is provided with a drug carrying bin and an atomization cavity, and the drug carrying bin is suitable for carrying a drug liquid bottle; the suction nozzle is arranged on the drug administration body and is communicated with the mist outlet end of the atomization cavity; the atomizing assembly is fixed in the atomizing cavity and is used for atomizing the liquid medicine; the temperature control assembly comprises a controller and a medicine identifier electrically connected with the controller, the controller is arranged in the medicine feeding body and electrically connected with the atomizing assembly, and the medicine identifier is arranged in the medicine carrying bin and is used for reading medicine label signals of a medicine liquid bottle in the medicine carrying bin; the controller is used for controlling the atomizing temperature of the atomizing assembly according to the medicine label signal. It can be understood that the medicine label information on the medicine bottle is read by arranging the medicine identifier in the medicine carrying bin, then the controller determines the upper limit of the use temperature of the corresponding medicine according to the medicine label information, and then the atomizing assembly is controlled to heat the medicine so that the temperature of the generated atomized gas is lower than the proper temperature of the corresponding upper limit of the temperature, thereby realizing the heating to the proper temperature corresponding to different medicines and realizing one device for multiple purposes; in addition, as the atomization heating temperature of different medicines is controlled in a targeted manner, the problem that the medicine effect is lost or changed due to the fact that the molecular structure of the medicines is damaged is avoided, the medicine effect of the medicines is ensured, and the toxicity of the medicines is avoided.

Drawings

In order to more clearly illustrate the embodiments of the present utility model or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, and it is obvious that the drawings in the following description are only some embodiments of the present utility model, and other drawings may be obtained according to the structures shown in these drawings without inventive effort for a person skilled in the art.

FIG. 1 is a schematic diagram of an embodiment of an electronic pulse applicator of the present utility model;

FIG. 2 is an exploded view of one embodiment of an electronic pulse applicator of the present utility model;

FIG. 3 is a cross-sectional view of one embodiment of an electronic pulse applicator of the present utility model;

FIG. 4 is a schematic diagram of a temperature control system in an embodiment of an electronic pulse applicator according to the present utility model.

Reference numerals illustrate:

10. a drug delivery body; 20. a suction nozzle; 30. an atomizing assembly; 40. a temperature control assembly; 50. a rechargeable battery; 110. a drug carrying bin; 120. an atomizing chamber; 130. a warming chamber; 140. a battery compartment; 100. a liquid medicine bottle; 410. a controller; 420. a drug identifier; 310. an atomizing sheet; 320. a sterile cotton stick; 330. a heat generating member; 430. a temperature sensor; 101. a cartridge; 102. an atomizing cylinder; 102a, a gas retention channel; 102b, a reflow chamber.

The achievement of the objects, functional features and advantages of the present utility model will be further described with reference to the accompanying drawings, in conjunction with the embodiments.

Detailed Description

The following description of the embodiments of the present utility model will be made clearly and fully with reference to the accompanying drawings, in which it is evident that the embodiments described are only some, but not all embodiments of the utility model. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.

It should be noted that, if directional indications (such as up, down, left, right, front, and rear … …) are included in the embodiments of the present utility model, the directional indications are merely used to explain the relative positional relationship, movement conditions, etc. between the components in a specific posture (as shown in the drawings), and if the specific posture is changed, the directional indications are correspondingly changed.

In addition, if there is a description of "first", "second", etc. in the embodiments of the present utility model, the description of "first", "second", etc. is for descriptive purposes only and is not to be construed as indicating or implying a relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include at least one such feature. In addition, if the meaning of "and/or" is presented throughout this document, it is intended to include three schemes in parallel, taking "a and/or B" as an example, including a scheme, or B scheme, or a scheme where a and B meet simultaneously. In addition, the technical solutions of the embodiments may be combined with each other, but it is necessary to base that the technical solutions can be realized by those skilled in the art, and when the technical solutions are contradictory or cannot be realized, the combination of the technical solutions should be considered to be absent and not within the scope of protection claimed in the present utility model.

The utility model provides an electronic pulse medicine feeder, in particular to a high-frequency pulse therapeutic apparatus, which is not limited herein.

Referring to fig. 1 to 4, in an embodiment of the present utility model, the electronic pulse applicator includes an administration body 10, a mouthpiece 20, an atomizing assembly 30, and a temperature control assembly 40; the drug delivery body 10 is formed with a drug loading bin 110 and an atomization cavity 120, and the drug loading bin 110 is suitable for loading a drug solution bottle 100; the suction nozzle 20 is arranged on the administration body 10 and communicated with the mist outlet end of the atomization cavity 120; the atomizing assembly 30 is fixed in the atomizing chamber 120 for atomizing the liquid medicine; the temperature control assembly 40 comprises a controller 410 and a medicine identifier 420 electrically connected with the controller 410, wherein the controller 410 is arranged in the medicine feeding body 10 and electrically connected with the atomizing assembly 30, and the medicine identifier 420 is arranged in the medicine carrying bin 110 and is used for reading medicine label signals of the medicine liquid bottle 100 in the medicine carrying bin 110; the controller 410 is configured to control the nebulization temperature of the nebulizing assembly 30 based on the drug label signal.

In this embodiment, the drug delivery body 10 may be cylindrical, square columnar, rectangular parallelepiped, or the like, may be assembled from a plurality of components, or may be a single component integrally formed, and the drug delivery body 10 may be made of plastic, or the like, and is not particularly limited herein.

The atomizing assembly 30 may employ an ultrasonic atomizing sheet 310, a metal heating wire, a heating sheet, a heating tube, or the like, but is not limited thereto.

In this embodiment, the electronic pulse drug feeder is provided with a circuit control system, and the circuit control system is composed of a temperature control board, a liquid control board, a gas control board, a voltage control board and the like, and is mainly used for achieving the purpose of controlling machinery. The controller 410 of the temperature control assembly 40 is disposed on the temperature control board, and the controller 410 may be a single chip microcomputer, a DSP, an FPGA, or the like, which is not limited herein. All of the control boards described above may be integrated on one circuit board and may be mounted inside the bottom end cap of the dosing body 10.

In this embodiment, the drug identifier 420 may be an RFID, a camera, or the like, which is not limited herein.

For verifying the temperature control effect of the electronic pulse drug feeder aiming at different drugs, the product, the comparison product 1 and the comparison product 2 are tested for multiple times respectively, wherein the comparison products 1 and 2 do not contain a temperature control system, the test drugs comprise ganoderma lucidum, medlar and ginseng, and the specific test results are shown in the following table 1:

table 1 comparison of temperature control

Through adding three kinds of chinese-medicinal material stoste respectively in the liquid medicine bottle 100 with contrast product 1, contrast product 2 and this application sample, the temperature that contains chinese herbal medicine stoste atomizing gas after contrast product 1 heats is respectively: 270 ℃, 270 ℃ and 270 ℃; the temperature of the atomized gas of the stock solution containing the Chinese herbal medicine after heating the comparison product 2 is respectively as follows: 290 ℃, 290 ℃; the temperature of the atomized gas of the stock solution containing the Chinese herbal medicine after the sample is heated is respectively as follows: 75 ℃, 57 ℃, 85 ℃. Experimental results show that the electronic pulse drug feeder with the temperature control system can control the temperature within a proper temperature range of three traditional Chinese medicinal materials, namely, within an optimal absorption efficiency temperature range.

It can be understood that the medicine identifier 420 is arranged in the medicine carrying bin 110 to read the medicine label information on the medicine bottle 100, then the controller 410 determines the upper limit of the use temperature of the corresponding medicine according to the medicine label information, and then the atomizing assembly 30 is controlled to heat the medicine so that the temperature of the generated atomized gas is lower than the proper temperature of the corresponding upper limit of the temperature, thereby realizing the heating to the proper temperature corresponding to different medicines and realizing one machine for multiple purposes; in addition, as the atomization heating temperature of different medicines is controlled in a targeted manner, the problem that the medicine effect is lost or changed due to the fact that the molecular structure of the medicines is damaged is avoided, the medicine effect of the medicines is ensured, and the toxicity of the medicines is avoided.

In order to test the absorptivity of the product, a blood alcohol concentration test is adopted, white spirit is selected as a test product, and ten mouths are inhaled within one minute after 52 degrees of white spirit is added into a medicine feeder. Blood alcohol concentration test was used after 10 minutes. It should be noted that the test method has the advantage of immediate detection effect, and does not represent that the product of the application can only reach higher absorptivity to the test product in the actual use process. In the comparative test, the samples, comparative product 1 and comparative product 2 of the present application were tested for alcohol content in 100ml of blood, respectively, and the specific test results are shown in table 2 below:

table 2 absorbance conversion comparison

By adding a certain brand of 52-degree white spirit into the liquid medicine bottles 100 of the comparison product 1, the comparison product 2 and the samples of the application respectively, the absorption rate of the comparison product 1 is 8mg/100ml, the absorption rate of the comparison product 2 is 12mg/100ml, and the absorption rate of the samples of the application is 37mg/100ml. Experimental results show that the absorption rate of the solution in the drug carrying bin 110 is greatly higher than that of other similar products.

To achieve a better aerosolization treatment, referring to fig. 2 and 3, in one embodiment, the aerosolization assembly 30 may include an aerosolization tab 310 and a sterile cotton wand 320, the aerosolization tab 310 being coupled to the sterile cotton wand 320, the sterile cotton wand 320 being adapted to be inserted into the medical fluid bottle 100; the atomizing sheet 310 is used for atomizing atomized liquid contained in the sterile cotton swab 320 through variable frequency vibration.

In the present embodiment, a heating cavity 130 is provided in the mouthpiece 20 or the drug delivery body 10, and the heating cavity 130 is communicated with the atomizing cavity 120; the atomizing assembly 30 further comprises a heating element 330, wherein the heating element 330 is arranged in the heating cavity 130 and is electrically connected with the controller 410; the controller 410 is further configured to control the heating element 330 to heat the liquefied liquid medicine droplets and the atomized gas in the heating chamber 130. In this way, the water droplets and the atomized gas condensed in the heating chamber 130 can be further heated and atomized, so that the liquid medicine is converted into mist with proper temperature as much as possible for human inhalation, and the phenomenon that the water droplets flow to other parts of the administration body 10 to influence the operation or leak liquid can be avoided.

The heating element 330 may be a heating wire metal tube, one end of which is communicated with the atomizing chamber 120, the other end of which is communicated with the suction nozzle 20, and a communication hole which is communicated with the heating chamber 130 is formed in the heating wire metal tube.

To further enhance the accuracy of the temperature control of the electronic pulse applicator, referring to fig. 3 and 4, in one embodiment, the temperature control assembly 40 may further include a temperature sensor 430, wherein the temperature sensor 430 is disposed at the mist outlet end of the heating chamber 130 and electrically connected to the controller 410; the temperature sensor 430 is configured to detect a mist-emitting temperature signal of the atomizing gas in the heating chamber 130, and the controller 410 is further configured to control the operation of the atomizing sheet 310 and/or the heating element 330 according to the mist-emitting temperature signal.

The temperature control system can ensure the drug effect of the drug, has no molecular damage, can ensure that the temperature of the heating cavity 130 is comfortable, and can ensure that the small molecular atomized gas generated by the heating cavity 130 and the drug sprayed by ultrasonic waves are combined and inhaled by a human body, thereby improving the use feeling, eliminating the rejection reaction of the human body, enabling the human body to absorb a larger amount, leading more atomized gas to enter the lung, greatly improving the absorption efficiency and ensuring the effective absorption of the liquid medicine.

In the present embodiment, the temperature sensor 430 may be a thermistor or the like, which is not limited herein.

The present utility model delivers an upper temperature limit to the controller 410 according to the upper temperature limit of use of different medicines by providing the replaceable medicine carrying cartridge 110 with a temperature information recognition function. The ultrasonic drug delivery cartridge 110 is provided with a drug identifier 420, for example: during production, different temperatures are input into the RFID chip of the medicine bottle according to different optimal atomization heating temperatures of different medicines. The chip is provided with an algorithm system, the highest temperature upper limit of the liquid medicine is written on the chip in the factory atomized liquid bottle through the algorithm system, the number on the chip is read by a medicine identifier 410 of the temperature control device, or a two-dimensional code or a bar code containing information such as a medicine name and proper heating temperature is arranged on the liquid medicine bottle 100 in a sticking or embedding mode, and then the two-dimensional code or the bar code is read through the corresponding medicine identifier 410, and then the atomization temperature is controlled by a control board. Different from the existing drug delivery device, the drug delivery device has the advantages that the drug delivery bin 110 with the information identification function is added, so that the drug effect is ensured, the drug delivery device is multipurpose, the drug can be flexibly matched and sucked according to different drugs, the drug effect is ensured, and the use cost of a user is reduced.

In one embodiment, the electronic pulse applicator may further include an air switch mounted in the applicator body 10 and electrically connected to the controller 410. The drug delivery body 10 comprises a drug carrying cylinder 101 and an atomization cylinder 102, wherein the drug carrying cylinder 101 forms a drug carrying bin 110, the atomization cylinder 102 forms an atomization cavity 120, and the drug carrying cylinder 101 and the atomization cylinder 102 are connected through magnetic attraction and fixed through a locking structure.

Currently, the drug delivery cartridge 110 of existing drug applicators is typically coupled to the nebulizing cartridge 102 using a magnet, which results in an insufficiently secure coupling of the drug delivery cartridge 110 to the nebulizing cartridge 102 and a tendency to fall out. However, the medicine carrying cylinder 101 and the atomizing cylinder 102 of the electronic pulse medicine feeder are connected through magnetic attraction and fixed through a locking structure, so that the connection stability of the medicine carrying cylinder and the atomizing cylinder is ensured.

In this embodiment, the magnetic attraction structure may include a plurality of pairs of magnets with positive and negative poles arranged in a staggered manner. The locking structure can be a spring locking manner, and can be composed of a spring and a hollow air needle tube, wherein the hollow air needle tube is arranged in the air switch channel, and the specific structure is not limited.

In this regard, the inventors also performed delay and release tests on the electronic pulse applicators of the present application with comparative product 1, comparative product 2, and the specific structures are shown in table 3 below:

table 3 comparison of use effects

Compared with the existing inhalation type instrument with the medicine carrying bin 110 on the market, the device has the advantages that the air switch and the corresponding channel structure are added in the structural innovation, the delay time of the device is shortest under the same inhalation pressure, the device shows that the user can capture the change of the internal and external pressure more accurately and rapidly when inhaling the gas, people can inhale atomized gas more conveniently and more conveniently, and the gas circulation is ensured to be smooth. In addition, in the falling test process, when three products fall from the height of one meter, the medicine carrying bin 110 connected with the suction nozzle 20 and the whole structure of the comparison product 1 and the comparison product 2 are separated to different degrees, and the medicine carrying bin 110 connected with the suction nozzle 20 and the product added with the locking structure of the locking pin are tightly and stably connected with the whole structure, so that the falling phenomenon is avoided.

To avoid turbulence or leakage of liquid in the atomizing chamber 120 due to mist condensation, and to ensure proper administration of the liquid by the dispenser, referring mainly to fig. 3, in one embodiment, an atomizing channel is disposed in the atomizing barrel 102, one end of the atomizing channel is located at the mist outlet end of the atomizing assembly 30, and the other end of the atomizing channel is in communication with the mist inlet end of the suction nozzle 20 for guiding the mist into the suction nozzle 20. The nebulization channel may comprise a gas retaining channel 102a and a back flow chamber 102b, the gas retaining channel 102a being arranged at the nebulizing end of the nebulizing assembly 30, the other end of the gas retaining channel 102a being in communication with the nebulizing end of the mouthpiece 20 for guiding the mist into the mouthpiece 20 in the length direction of the dosing body 10; a return chamber 102b is provided in the dosing body 10 and at least partially surrounds the gas retaining channel 102a for returning droplets of liquid drug agglomerated by the atomizing gas within the chamber to the atomizing assembly 30. The gas retaining channel 102a reduces the speed and quantity of gas passing through in a flow limiting mode, avoids liquefaction of ultrasonic atomization gas, ensures normal administration, and simultaneously greatly improves the utilization rate of the ultrasonic atomization gas and ensures the drug effect.

The principle of the function is that the medicine carrying bin 110 sends medicine liquid to the ultrasonic atomization sheet 310 through the insertion of the sterile cotton stick 320, the ultrasonic atomization sheet 310 atomizes the atomized liquid, and atomized gas is guided into the air inlet of the upper heating element 330 through the gas retaining channel 102 a. The gas retaining channel 102a can limit the flow of the atomized matters generated by the vibration of the ultrasonic atomizing sheet 310, so as to prevent the mist from condensing to form liquid and ensure normal administration.

The electronic pulse drug delivery device combines the ultrasonic atomization device with the heating atomization device, and the ultrasonic atomization gas generated by the ultrasonic atomizer reaches the heating part 330 through the atomization channel to heat the ultrasonic atomization material, so that the ultrasonic atomization material inhaled by a person does not generate rejection reaction, and the experience is enhanced.

To enhance the cruising ability of the electronic pulse dose apparatus, and to facilitate use by a user, referring to fig. 2 and 3, in some embodiments, the drug loading cartridge 101 is further formed with a battery compartment 140 spaced apart from the drug loading compartment 110, and a rechargeable battery 50 is disposed in the battery compartment 140, and the rechargeable battery 50 is electrically connected to the controller 410 and provides power to the entire electronic pulse dose apparatus.

In addition, it is worth mentioning that the atomized substances of some medicines are unacceptable in taste without adding seasoning, the experience is poor, and the using viscosity of users is reduced. Some drugs cannot be mixed in advance, and must be mixed at the time of use (e.g., antibiotics and physiological saline, and hormone and physiological saline, for example) in order to ensure the efficacy. For preserving the efficacy, part of the medicines are stored in a powder form (for example, freeze-dried powder and the like), and the powder is required to be fused with a solution when in use. In this regard, the present utility model solves the problem that the atomized aerosol of a part of medicines is unacceptable in taste and poor in experience without adding flavoring agents by providing a combined drug carrying bin 110 that can be made by the user himself. The combined drug delivery cartridge 110 may include at least two interconnected sub-cartridges, one of which may be pre-filled and the other of which may be self-administered by the user with the desired drug. The drug taste of the drug dispenser can be adjusted and customized, and the user experience is enhanced. The product can mix medicines in advance, match the two medicines and inhale simultaneously. Different from the existing drug delivery device, the user can realize the optimization of experience through a pre-canning and self-manual mode, the utility model can self-manual, and the user can selectively fill different forms (such as freeze-dried powder or liquid) and different tastes (added taste additives: yoghurt, strawberries and the like) according to the preference of the user.

The foregoing description is only of the optional embodiments of the present utility model, and is not intended to limit the scope of the utility model, and all the equivalent structural changes made by the description of the present utility model and the accompanying drawings or the direct/indirect application in other related technical fields are included in the scope of the utility model.

Claims

1. An electronic pulse applicator, comprising:

2. The electronic pulse applicator of claim 1, wherein the aerosolization assembly comprises an aerosolization tab and a sterile cotton wand, the aerosolization tab being coupled to the sterile cotton wand, the sterile cotton wand being adapted to be inserted into a vial of medical fluid; the atomization sheet is used for atomizing atomization liquid contained in the sterile cotton stick through variable frequency vibration.

3. The electronic pulse applicator of claim 2, wherein a warming chamber is provided within the mouthpiece or the dosing body, the warming chamber being in communication with the nebulizing chamber; the atomizing assembly further comprises a heating element which is arranged in the heating cavity and is electrically connected with the controller; the controller is also used for controlling the heating element to heat the liquid medicine water drops and the atomized gas in the heating cavity.

4. The electronic pulse applicator of claim 3, wherein the temperature control assembly further comprises a temperature sensor disposed at the mist outlet end of the warming chamber and electrically connected to the controller; the temperature sensor is used for detecting a mist outlet temperature signal of the atomizing gas in the heating cavity, and the controller is also used for controlling the atomizing sheet and/or the heating element to work according to the mist outlet temperature signal.

5. The electronic pulse medicine feeder according to claim 3, wherein the heating element is a heating wire metal tube, one end of the heating wire metal tube is communicated with the atomizing cavity, the other end of the heating wire metal tube is communicated with the suction nozzle, and a communication hole communicated with the heating cavity is formed in the heating wire metal tube.

6. The electronic pulse applicator of claim 1, wherein the drug identifier is an RFID radio frequency identifier or a camera.

7. The electronic pulse applicator of claim 1, further comprising an air switch mounted in the applicator body and electrically connected to the controller.

8. The electronic pulse applicator of claim 7, wherein the drug delivery body comprises a drug carrying cartridge and an atomizing cartridge, the drug carrying cartridge forming the drug carrying compartment, the atomizing cartridge forming the atomizing chamber, the drug carrying cartridge being magnetically attached to the atomizing cartridge and secured by a locking mechanism.

9. The electronic pulse applicator of claim 8, wherein an atomizing passage is provided in the atomizing barrel, one end of the atomizing passage is positioned at the mist outlet end of the atomizing assembly, and the other end of the atomizing passage is in communication with the mist inlet end of the mouthpiece for directing mist into the mouthpiece.

10. The electronic pulse applicator of claim 8, wherein the drug loading cartridge is further formed with a battery compartment disposed spaced apart from the drug loading compartment, the battery compartment housing a rechargeable battery, the rechargeable battery being electrically connected to the controller.